MA43691A - Promédicaments du modulateur du récepteur de progesterone (sprm) (11.bêta.,17.bêta.)-17-hydroxy-11-[4-(méthylsulphonyle)phenyle]-17-(pentafluoroéthyl)estra-4,9-dièn-3-one - Google Patents
Promédicaments du modulateur du récepteur de progesterone (sprm) (11.bêta.,17.bêta.)-17-hydroxy-11-[4-(méthylsulphonyle)phenyle]-17-(pentafluoroéthyl)estra-4,9-dièn-3-oneInfo
- Publication number
- MA43691A MA43691A MA043691A MA43691A MA43691A MA 43691 A MA43691 A MA 43691A MA 043691 A MA043691 A MA 043691A MA 43691 A MA43691 A MA 43691A MA 43691 A MA43691 A MA 43691A
- Authority
- MA
- Morocco
- Prior art keywords
- beta
- sprm
- estra
- methylsulphonyl
- pentafluoroethyl
- Prior art date
Links
- DBLOJPKZEOYNBN-SQNIBIBYSA-N (8s,13s,14s)-13-methyl-2,6,7,8,11,12,14,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-3-one Chemical compound C1CC2=CC(=O)CCC2=C2[C@@H]1[C@@H]1CCC[C@@]1(C)CC2 DBLOJPKZEOYNBN-SQNIBIBYSA-N 0.000 title 1
- IBPHXKCFBXEFQP-UHFFFAOYSA-N 1,1,1,2,2-pentafluoroethane Chemical class F[C](F)C(F)(F)F IBPHXKCFBXEFQP-UHFFFAOYSA-N 0.000 title 1
- -1 METHYLSULPHONYL Chemical class 0.000 title 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 239000002379 progesterone receptor modulator Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16158598.9A EP3214092A1 (fr) | 2016-03-04 | 2016-03-04 | Promédicaments du modulateur du récepteur de progesterone (sprm) (11.bêta.,17.bêta.)-17-hydroxy-11-[4-(méthylsulphonyle)phenyle]-17-(pentafluoroéthyl)estra-4,9-dièn-3-one |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA43691A true MA43691A (fr) | 2021-03-17 |
Family
ID=55486547
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA043691A MA43691A (fr) | 2016-03-04 | 2017-03-01 | Promédicaments du modulateur du récepteur de progesterone (sprm) (11.bêta.,17.bêta.)-17-hydroxy-11-[4-(méthylsulphonyle)phenyle]-17-(pentafluoroéthyl)estra-4,9-dièn-3-one |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10894805B2 (fr) |
| EP (2) | EP3214092A1 (fr) |
| JP (1) | JP2019511486A (fr) |
| KR (1) | KR20180118135A (fr) |
| CN (1) | CN108779142A (fr) |
| AU (1) | AU2017226922A1 (fr) |
| BR (1) | BR112018067517A2 (fr) |
| CA (1) | CA3016369A1 (fr) |
| CL (1) | CL2018002523A1 (fr) |
| CO (1) | CO2018009264A2 (fr) |
| CR (1) | CR20180426A (fr) |
| MA (1) | MA43691A (fr) |
| MX (1) | MX2018010658A (fr) |
| RU (1) | RU2018134045A (fr) |
| SG (1) | SG11201806771RA (fr) |
| WO (1) | WO2017148977A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3214092A1 (fr) | 2016-03-04 | 2017-09-06 | Bayer Pharma Aktiengesellschaft | Promédicaments du modulateur du récepteur de progesterone (sprm) (11.bêta.,17.bêta.)-17-hydroxy-11-[4-(méthylsulphonyle)phenyle]-17-(pentafluoroéthyl)estra-4,9-dièn-3-one |
| EP3384913A1 (fr) | 2017-04-03 | 2018-10-10 | Bayer Pharma Aktiengesellschaft | Modulateurs sélectifs du récepteur de la progestérone et niveau d' strogène stabilisé chez un patient |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA8231B (en) | 1981-01-09 | 1982-11-24 | Roussel Uclaf | New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained |
| EP0683172B1 (fr) * | 1994-05-19 | 1997-08-13 | Akzo Nobel N.V. | Dérivés 11,21-bisphényle-19-nor-pregnanes |
| DE19706061A1 (de) | 1997-02-07 | 1998-08-13 | Schering Ag | Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette |
| AU3266899A (en) * | 1998-03-06 | 1999-09-20 | Oxford Biomedica (Uk) Limited | Enhanced prodrug activation |
| JP2004520411A (ja) | 2001-01-09 | 2004-07-08 | シエーリング アクチエンゲゼルシャフト | 不妊症処理の間の促進された子宮内膜成熟を阻害するための抗ゲスタゲンの使用 |
| JP2002233378A (ja) * | 2001-02-07 | 2002-08-20 | Nihon Nosan Kogyo Kk | ヒト由来のチトクロムｐ４５０分子種を認識する抗体 |
| DE102006054535A1 (de) * | 2006-11-15 | 2008-05-21 | Bayer Schering Pharma Aktiengesellschaft | Progesteronrezeptorantagonisten |
| EP2448422A1 (fr) | 2009-07-02 | 2012-05-09 | University College Cork, National University Of Irland Cork | Procédé pour produire une base de gomme |
| DE102009034362A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
| DE102010007719A1 (de) * | 2010-02-10 | 2011-08-11 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Progesteronrezeptorantagonisten |
| DE102010007722A1 (de) * | 2010-02-10 | 2011-08-11 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Progesteronrezeptorantagonisten |
| DE102011088270A1 (de) * | 2011-12-12 | 2013-06-13 | Bayer Intellectual Property Gmbh | (11ß ,17ß)-17-hydroxy-11-[4-(methylsulfonyl)phenyl]-17-(pentafluorethyl)estra-4,9-dien-3-on zur Behandlung von Morbus Charcot Marie Toot |
| EA032481B1 (ru) | 2013-04-11 | 2019-06-28 | Байер Фарма Акциенгезельшафт | Дозированная форма антагониста рецептора прогестерона |
| EP3417863A1 (fr) * | 2015-05-18 | 2018-12-26 | Bayer Pharma Aktiengesellschaft | Modulateur sélectif du récepteur de la progestérone (sprm) pour son utilisation dans le traitement des saignements menstruels abondants |
| KR102396177B1 (ko) | 2016-03-04 | 2022-05-09 | 반더빌트유니버시티 | 치환된 인돌 ｍｃｌ-1 억제제 |
| EP3214092A1 (fr) | 2016-03-04 | 2017-09-06 | Bayer Pharma Aktiengesellschaft | Promédicaments du modulateur du récepteur de progesterone (sprm) (11.bêta.,17.bêta.)-17-hydroxy-11-[4-(méthylsulphonyle)phenyle]-17-(pentafluoroéthyl)estra-4,9-dièn-3-one |
-
2016
- 2016-03-04 EP EP16158598.9A patent/EP3214092A1/fr not_active Withdrawn
-
2017
- 2017-03-01 RU RU2018134045A patent/RU2018134045A/ru not_active Application Discontinuation
- 2017-03-01 CO CONC2018/0009264A patent/CO2018009264A2/es unknown
- 2017-03-01 SG SG11201806771RA patent/SG11201806771RA/en unknown
- 2017-03-01 CA CA3016369A patent/CA3016369A1/fr not_active Abandoned
- 2017-03-01 WO PCT/EP2017/054704 patent/WO2017148977A1/fr not_active Ceased
- 2017-03-01 EP EP17707881.3A patent/EP3423466A1/fr not_active Withdrawn
- 2017-03-01 MX MX2018010658A patent/MX2018010658A/es unknown
- 2017-03-01 BR BR112018067517A patent/BR112018067517A2/pt not_active IP Right Cessation
- 2017-03-01 KR KR1020187025053A patent/KR20180118135A/ko not_active Ceased
- 2017-03-01 AU AU2017226922A patent/AU2017226922A1/en not_active Abandoned
- 2017-03-01 CR CR20180426A patent/CR20180426A/es unknown
- 2017-03-01 US US16/082,025 patent/US10894805B2/en not_active Expired - Fee Related
- 2017-03-01 JP JP2018546493A patent/JP2019511486A/ja active Pending
- 2017-03-01 CN CN201780014127.0A patent/CN108779142A/zh active Pending
- 2017-03-01 MA MA043691A patent/MA43691A/fr unknown
-
2018
- 2018-09-04 CL CL2018002523A patent/CL2018002523A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017148977A1 (fr) | 2017-09-08 |
| EP3214092A1 (fr) | 2017-09-06 |
| CN108779142A (zh) | 2018-11-09 |
| RU2018134045A (ru) | 2020-04-06 |
| RU2018134045A3 (fr) | 2020-04-27 |
| EP3423466A1 (fr) | 2019-01-09 |
| CL2018002523A1 (es) | 2018-12-21 |
| US10894805B2 (en) | 2021-01-19 |
| CO2018009264A2 (es) | 2018-09-20 |
| AU2017226922A1 (en) | 2018-08-23 |
| US20190367555A1 (en) | 2019-12-05 |
| KR20180118135A (ko) | 2018-10-30 |
| CR20180426A (es) | 2018-11-21 |
| MX2018010658A (es) | 2019-01-17 |
| CA3016369A1 (fr) | 2017-09-08 |
| SG11201806771RA (en) | 2018-09-27 |
| BR112018067517A2 (pt) | 2019-01-02 |
| JP2019511486A (ja) | 2019-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL283754A (en) | Anti-claudin antibodies, preparations containing them and their uses | |
| IL279015A (en) | Anti-interleukin-17A antibody, its pharmaceutical preparation and its use | |
| PL3843561T3 (pl) | Urządzenie do dostarczania aerozolu ze zintegrowanym przewodnikiem cieplnym | |
| IL268588A (en) | Anti-gprc5d antibodies, compositions comprising same and uses thereof | |
| EP3585429A4 (fr) | Anticorps anti-il31 à usage vétérinaire | |
| IL261200A (en) | Antibodies specific to human poliovirus receptor (pvr) | |
| HUE064753T2 (hu) | Claudin 18.2 elleni antitesteket tartalmazó gyógyszer konjugátumok | |
| DK3408295T5 (da) | Farmaceutisk sammensætning, som omfatter bispecifikke antistofkonstruktioner | |
| DK3125934T3 (da) | Kimær antigenreceptor (car) med antigenbindende domæner over for den konstante region af t-cellereceptor beta | |
| IL276746B1 (en) | Kir3dl3 as a hhla2 receptor, anti-hhla2 antibodies and their uses | |
| CY1123295T1 (el) | Κρυσταλλικες μορφες της 5-χλωρο-ν4-[-2-(διμεθυλοφωσφορυλο) φαινυλο]-ν2-{2-μεθοξυ-4-[4-(4-μεθυλοπιπεραζιν-1-υλο)πιπεριδιν- 1-υλο]πυριμιδινο-2,4-διαμινης | |
| DK3283110T3 (da) | Antistoffer rettet mod interleukin-36-receptor (il-36r) | |
| EP3632907C0 (fr) | Dérivé de n-(azaaryl)cyclolactame-1-carboxamide, son procédé de préparation et son utilisation | |
| DK3362477T3 (da) | Antigenbindingsproteiner, der aktiverer leptinreceptoren | |
| EP3498779A4 (fr) | Composition de silicone particulaire durcissable, élément semi-conducteur comprenant la composition de silicone particulaire durcissable et procédé de moulage pour élément semi-conducteur comprenant la composition de silicone particulaire durcissable | |
| DK3242666T5 (da) | Forbindelsee til anvendelse i behandling af tilstande, der er forbundet med SIP1-receptoren | |
| PL4071079T3 (pl) | Zawór odmierzający do dozowania produktu | |
| EP3494125A4 (fr) | Compositions comprenant du 5-cholestène-3, 25-diol,3-sulfate (25 h3s) ou un sel pharmaceutiquement acceptable de celui-ci et au moins un oligosaccharide cyclique | |
| DK3672631T5 (da) | Farmaceutiske sammensætninger indeholdende anti-beta-amyloid-antistoffer | |
| DK3227273T3 (da) | Sammensætninger, som omfatter 2-((1-(2(4-fluorphenyl)-2-oxoethyl)piperidin-4-yl)methyl)isoindolin-1-on, til behanlding af skizofreni | |
| LT3313408T (lt) | Kontraceptikas drospirenono pagrindu, skirtas pacientėms, turinčioms antsvorio | |
| SG10202012778YA (en) | Pharmaceutical composition comprising anti-human tslp receptor antibody | |
| DK3458480T3 (da) | Antistof rettet mod endothelin-receptoren beta-subtype | |
| DK3613803T3 (da) | Sammensætning til silikonegummimasser. | |
| DK3303323T3 (da) | Heterocykliske forbindelser af 3,3-difluorpiperidincarbamat som NR2B-NMDA-receptorantagonister |